Although certain SMTA-OM readouts do manifest pronounced differences among the three ALT+ cells, analysis of additional ALT+ cell lines is warranted to further confirm SMTA-OM’s capacity to discern between different subtypes of ALT+ cancer cells. This evidence concerns the gene GPT and cancer.